Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020–2022
Scientific Reports · 04.09.2024 · 14 (1)
DOI: 10.1038/s41598-024-71492-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, online erschienen am 04.09.2024. Verfasst von Orna Schwartz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections, Anti-Bacterial Agents, Virulence Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Biofilm formation and toxin production are some of the virulence factors of Clostridioides difficile (C. difficile), which causes hospital-acquired C. difficile infection (HA-CDI). This work investigated the prevalence and distribution of different strains recovered from HA-CDI patients hospitalized in 4 medical centres across Israel, and characterized strains' virulence factors and antibiotic susceptibility. One-hundred and eighty-eight faecal samples were collected. C. difficile 's toxins were detected by the CerTest Clostridium difficile GDH + Toxin A + B combo card test kit. Toxin loci PaLoc and PaCdt were detected by whole-genome sequencing (WGS). Multi-locus sequence typing (MLST) was performed to classify strains. Biofilm production was assessed by crystal violet. Antibiotic susceptibility was determined using Etest. Fidaxomicin susceptibility was tested via agar dilution. Sequence type (ST) 42 was the most (13.8%) common strain. All strains harboured the 2 toxins genes; 6.9% had the binary toxin. Most isolates were susceptible to metronidazole (98.9%) and vancomycin (99.5%). Eleven (5.85%) isolates were fidaxomicin-resistant. Biofilm production capacity was associated with ST (p < 0.001). In conclusion, a broad variety of C. difficile strains circulate in Israel's medical centres. Further studies are needed to explore the differences and their contribution to HA-CDI epidemiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
- Clinical Microbiology Laboratory, The Edith Wolfson Medical Center, Holon, Israel, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Clinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Israel, affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
- Shamir Medical Center, B'er Ya'akov, Israel.
- Infectious Diseases Unit, The Edith Wolfson Medical Center, Holon, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Zitieren
APA
Schwartz, O., Rohana, H., Azrad, M., Shor, A., Rainy, N., Maor, Y., Nesher, L., Sagi, O., & Peretz, A. (2024). Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020–2022. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-71492-2
Vancouver
Schwartz O, Rohana H, Azrad M, Shor A, Rainy N, Maor Y, et al. Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020–2022. Scientific Reports. 2024;14(1). doi:10.1038/s41598-024-71492-2
BibTeX
@article{Schwartz2024,
author = {Schwartz, Orna and Rohana, Hanan and Azrad, Maya and Shor, Anna and Rainy, Nir and Maor, Yasmin and Nesher, Lior and Sagi, Orli and Peretz, Avi},
title = {Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020–2022},
journal = {Scientific Reports},
year = {2024},
volume = {14},
number = {1},
doi = {10.1038/s41598-024-71492-2}
}
EUVIMED